A Conversation about the TWiTCH Trial with Dr. Russell Ware and Dr. Michael DeBaun
In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (University of Cincinnati and Cincinnati Children's Hospital), the national Principal Investigator for this NIH-funded trial conducted under the sponsorship of an FDA IND, joins Dr. DeBaun in this conversation. You can find the diffusion online at www.hematology.org/Thehematologist/Diffusion/4943.aspx.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (University of Cincinnati and Cincinnati Children's Hospital), the national Principal Investigator for this NIH-funded trial conducted under the sponsorship of an FDA IND, joins Dr. DeBaun in this conversation. You can find the diffusion online at www.hematology.org/Thehematologist/Diffusion/4943.aspx.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
